NHANES 2013-2014 Overview - Centers for Disease Control and Prevention

                                               
  • NHANES 2013-2014: Phthalates and Plasticizers Metabolites Chile price
  • NHANES 2013-2014: Phthalates and Plasticizers Metabolites Chile manufacturer
  • NHANES 2013-2014: Phthalates and Plasticizers Metabolites Chile manufacturer

NHANES 2013-2014: Phthalates and Plasticizers Metabolites - Urine Data

                                               
  • NHANES 2013-2014: Phthalates and Plasticizers Metabolites Chile price
  • NHANES 2013-2014: Phthalates and Plasticizers Metabolites Chile manufacturer
  • NHANES 2013-2014: Phthalates and Plasticizers Metabolites Chile manufacturer

PHTHTE_J - Centers for Disease Control and Prevention

                                               
  • NHANES 2013-2014: Phthalates and Plasticizers Metabolites Chile price
  • NHANES 2013-2014: Phthalates and Plasticizers Metabolites Chile manufacturer
  • NHANES 2013-2014: Phthalates and Plasticizers Metabolites Chile manufacturer

SSPHTE_H - Centers for Disease Control and Prevention

                                               
  • NHANES 2013-2014: Phthalates and Plasticizers Metabolites Chile price
  • NHANES 2013-2014: Phthalates and Plasticizers Metabolites Chile manufacturer
  • NHANES 2013-2014: Phthalates and Plasticizers Metabolites Chile manufacturer

Non-persistent exposures from plasticizers or plastic

                                               
  • NHANES 2013-2014: Phthalates and Plasticizers Metabolites Chile price
  • NHANES 2013-2014: Phthalates and Plasticizers Metabolites Chile manufacturer
  • NHANES 2013-2014: Phthalates and Plasticizers Metabolites Chile manufacturer
  • Which phthalate metabolites are available in the NHANES database?
  • Flow chart algorithm There are four urinary DEHP metabolites available in the NHANES 2013–2014 database, including mono (2-ethylhexyl) phthalate (MEHP), mono (2-ethyl-5-oxohexyl) phthalate (MEOHP), mono (2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), and mono (2-ethyl-5-carboxypentyl) phthalate (MECPP).
  • Are phthalates endocrine disruptors?
  • Phthalates are plasticizers in various products and regarded as endocrine disruptors due to their anti-androgen effects. Environmental occurrence and toxicities of parent phthalates have been widely reported, while the current state of knowledge on their metabolites is rarely summarized.
  • Which metabolites are measured in NHANES 2013-2014?
  • In NHANES 2013–2014, urinary DEHP metabolites were measured in one-third of participants aged 6 years and older, and serum NfL was assessed in one-half of subjects aged 20 to 75 years. Out of the 9770 participants, data for both covariates were available for 701 study subjects.
  • How phthalates are metabolized?
  • Phthalates can be rapidly metabolized to their respective primary monoesters and further to oxidized metabolites in human body (Guo et al., 2011b). In detail, normally metabolic pathway of phthalates involves two steps: in the first phase, phthalates are metabolized to monoesters by esterase and lipase in intestines or other tissues.
  • How do phthalate metabolites differ from parent phthalates?
  • Metabolites display different toxic mechanism compared to parent phthalates. Differences exist in distribution of phthalate metabolites in multiple human specimens. Urinary profiles of phthalates vary markedly for people on different continents. Reasonable FUE data are suggested for phthalate exposure assessment by human experiments.
  • What models are used to estimate human daily intake of phthalates?
  • The following models used to estimate human daily intake (EDI) of phthalates are mainly based on their excretion rates and urinary mPAE concentrations (Table S4). The model M1 was initially proposed by David (2000) and Kohn and Needham (2000), which was enlightened by a report from Blount et al. (2000b).